Back to calendar
Recursion Pharmaceuticals, Inc. (RXRX) Earnings
RXRX reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.24
Actual EPS: $-0.22
Company overview
Market Cap$1.6B
SectorHealth Technology
IndustryBiotechnology